Antimicrobial resistance of urinary tract pathogens in children in Crete, Greece

被引:24
作者
Anatoliotaki, Maria
Galanakis, Emmanouil
Schinaki, Athina
Stefanaki, Sofia
Mavrokosta, Maria
Tsilimigaki, Amalia
机构
[1] Venizel Gen Hosp, Dept Paediat, Iraklion, Crete, Greece
[2] Univ Crete, Infect Dis Unit, Dept Paediat, Iraklion, Crete, Greece
关键词
D O I
10.1080/00365540701199899
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The aim of the present study was to identify the organisms responsible for community acquired febrile UTI in children and to investigate their susceptibility to commonly used antibiotics. A 5-y prospective analysis was performed in children hospitalized for a first episode of UTI, in Crete, Greece. A total of 262 children, 40.1% males and 59.9% females, aged 0.08 to 13 y, were enrolled in the study. Escherichia coli (E. coli) was the leading uropathogen. Antimicrobial resistance of E. coli isolates was most commonly to ampicillin (56.4%) followed by trimethoprim-sulfamethoxazole (TMP-SMX) (27.3%), cefaclor (22.5%), amoxicillin-clavulanate (15.5%), gentamicin (4.9%), cefuroxime (3.1%), nitrofurantoin (2.6%), and ceftriaxone (1.6%). Interestingly, a significant decrease in E. coli resistance to TMP-SMX was observed during the study period. Resistance to ampicillin, TMP-SMX and cefaclor was noted for 61%, 28% and 27% of the total uropathogens, respectively, making these agents inappropriate for empirical treatment of febrile UTI in our region. A larger number of pathogens may be empirically treated with amoxicillin-clavulanate. More than 90% of the uropathogens are susceptible to cefuroxime, ceftriaxone, gentamicin, and nitrofurantoin. In conclusion, several of the first-line agents for empirical treatment of childhood UTI seem to have become ineffective in the area of this study.
引用
收藏
页码:671 / 675
页数:5
相关论文
共 25 条
[1]   Urinary tract infection caused by Shigella sonnei [J].
Anatoliotaki, M ;
Galanakis, E ;
Tsekoura, T ;
Schinaki, A ;
Stefanaki, S ;
Tsilimigaki, A .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2003, 35 (6-7) :431-433
[2]   Randomised controlled trial of three day versus 10 day intravenous antibiotics in acute pyelonephritis: effect on renal scarring [J].
Benador, D ;
Neuhaus, TJ ;
Papazyan, JP ;
Willi, UV ;
Engel-Bicik, I ;
Nadal, D ;
Slosman, D ;
Mermillod, B ;
Girardin, E .
ARCHIVES OF DISEASE IN CHILDHOOD, 2001, 84 (03) :241-246
[3]   Community-acquired enterococcal urinary tract infections [J].
Bitsori, M ;
Maraki, S ;
Raissaki, M ;
Bakantaki, A ;
Galanakis, E .
PEDIATRIC NEPHROLOGY, 2005, 20 (11) :1583-1586
[4]   Pediatric urinary tract infections [J].
Chang, Steven L. ;
Shortliffe, Linda D. .
PEDIATRIC CLINICS OF NORTH AMERICA, 2006, 53 (03) :379-+
[5]   CLINICAL AND BACTERIOLOGICAL EFFECTS OF THERAPY OF URINARY-TRACT INFECTION IN PRIMARY HEALTH-CARE - RELATION TO INVITRO SENSITIVITY TESTING [J].
FERRY, S ;
BURMAN, LG ;
HOLM, SE .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1988, 20 (05) :535-544
[6]   Changes in antimicrobial resistance of Escherichia coli causing urinary tract infections in hospitalized children [J].
Fritzsche, M ;
Ammann, RA ;
Droz, S ;
Bianchetti, MG ;
Aebi, C .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2005, 24 (03) :233-235
[7]   Antibiotic resistance of urinary tract pathogens and rationale for empirical intravenous therapy [J].
Haller, M ;
Brandis, M ;
Berner, R .
PEDIATRIC NEPHROLOGY, 2004, 19 (09) :982-986
[8]   Oral versus initial intravenous therapy for urinary tract infections in young febrile children [J].
Hoberman, A ;
Wald, ER ;
Hickey, RW ;
Baskin, M ;
Charron, M ;
Majd, M ;
Kearney, DH ;
Reynolds, EA ;
Ruley, J ;
Janosky, JE .
PEDIATRICS, 1999, 104 (01) :79-86
[9]  
JACK SE, 2004, NELSON TXB PEDIAT, P1785
[10]   Mechanisms of renal damage owing to infection [J].
Jahnukainen, T ;
Chen, M ;
Celsi, G .
PEDIATRIC NEPHROLOGY, 2005, 20 (08) :1043-1053